These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 22681585)
21. Nanoparticles: A personal experience for formulating poorly water soluble drugs. Cooper ER J Control Release; 2010 Feb; 141(3):300-2. PubMed ID: 19822177 [TBL] [Abstract][Full Text] [Related]
22. Use of prebiotics in oral delivery of bioactive compounds: a nanotechnology perspective. Heidarpour F; Mohammadabadi MR; Zaidul IS; Maherani B; Saari N; Hamid AA; Abas F; Manap MY; Mozafari MR Pharmazie; 2011 May; 66(5):319-24. PubMed ID: 21699064 [TBL] [Abstract][Full Text] [Related]
23. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs. Wang XQ; Zhang Q Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229 [TBL] [Abstract][Full Text] [Related]
24. Advanced drug delivery nanosystems: perspectives and regulatory issues. Demetzos C Adv Exp Med Biol; 2015; 822():195-8. PubMed ID: 25416990 [TBL] [Abstract][Full Text] [Related]
26. Cyclodextrins in drug delivery. Loftsson T; Jarho P; Másson M; Järvinen T Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758 [TBL] [Abstract][Full Text] [Related]
27. Stability of nanosuspensions in drug delivery. Wang Y; Zheng Y; Zhang L; Wang Q; Zhang D J Control Release; 2013 Dec; 172(3):1126-41. PubMed ID: 23954372 [TBL] [Abstract][Full Text] [Related]
28. Nanosponges- Versatile Platform as Drug Carrier. Kandekar U; Pujari R; Munot N; Chorge T; Lone K; Kamble P; Kishanchand K Recent Pat Nanotechnol; 2023; 17(2):91-103. PubMed ID: 36748244 [TBL] [Abstract][Full Text] [Related]
29. Diversity of β-cyclodextrin-based nanosponges for transformation of actives. Pawar S; Shende P; Trotta F Int J Pharm; 2019 Jun; 565():333-350. PubMed ID: 31082468 [TBL] [Abstract][Full Text] [Related]
31. [Nano-particles--pharmaceutical "dwarves" with know-how]. Ziegler AS Med Monatsschr Pharm; 2008 Dec; 31(12):455-66; quiz 467-8. PubMed ID: 19133594 [TBL] [Abstract][Full Text] [Related]
32. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. Dahan A; Hoffman A J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294 [TBL] [Abstract][Full Text] [Related]
33. Electrospun nanofibers in drug delivery: recent developments and perspectives. Williams GR; Chatterton NP; Nazir T; Yu DG; Zhu LM; Branford-White CJ Ther Deliv; 2012 Apr; 3(4):515-33. PubMed ID: 22834080 [TBL] [Abstract][Full Text] [Related]
34. Magnetic micro- and nano-particle-based targeting for drug and gene delivery. Dobson J Nanomedicine (Lond); 2006 Jun; 1(1):31-7. PubMed ID: 17716207 [TBL] [Abstract][Full Text] [Related]
35. Advances in lipid nanodispersions for parenteral drug delivery and targeting. Constantinides PP; Chaubal MV; Shorr R Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269 [TBL] [Abstract][Full Text] [Related]
37. Biosensing and drug delivery at the microscale : novel devices for controlled and responsive drug delivery. Robitzki AA; Kurz R Handb Exp Pharmacol; 2010; (197):87-112. PubMed ID: 20217527 [TBL] [Abstract][Full Text] [Related]
38. Nanosponges -A Promising Novel Drug Delivery System. Pandey P; Purohit D; Dureja H Recent Pat Nanotechnol; 2018; 12(3):180-191. PubMed ID: 30251614 [TBL] [Abstract][Full Text] [Related]
39. Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications. Jaspart S; Piel G; Delattre L; Evrard B Expert Opin Drug Deliv; 2005 Jan; 2(1):75-87. PubMed ID: 16296736 [TBL] [Abstract][Full Text] [Related]